Video Experimental Relacionado
Updated: Sep 10, 2025
09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.9K
Innovaciones nanotecnológicas en el tratamiento de la tuberculosis pediátrica: tendencias actuales y perspectivas
Taiwo Oreoluwa Ajayi1, Madan Sai Poka1, Bwalya Angel Witika1
1Department of Pharmaceutical Science, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Frontiers in drug delivery
|August 21, 2025
Resumen
El tratamiento de la tuberculosis pediátrica (TB) se enfrenta a desafíos debido a formulaciones inadecuadas para adultos y mala palatabilidad. Se necesitan nuevos sistemas de administración de fármacos, incluida la nanotecnología, para terapias eficaces y amigables para la tuberculosis pediátrica.
Área de la Ciencia:
- Enfermedades infecciosas pediátricas
- Ciencias farmacéuticas
- Sistemas de administración de medicamentos
Sus antecedentes:
- La tuberculosis pediátrica (TB) sigue siendo una preocupación importante para la salud mundial, ya que causa una morbilidad y mortalidad considerables.
- Los niños son más susceptibles a la tuberculosis, con una rápida propagación a sitios extrapulmonares.
- Los tratamientos actuales para niños a menudo usan formulaciones para adultos, lo que lleva a inexactitudes en la dosificación y problemas de adherencia.
Objetivo del estudio:
- Revisar las formulaciones de tuberculosis pediátrica orales disponibles.
- Discutir nuevos sistemas de administración de fármacos por vía oral para la tuberculosis pediátrica.
- Explorar el potencial de la nanotecnología en el tratamiento de la tuberculosis pediátrica mediante un análisis FODA.
Principales métodos:
- Revisión de la literatura sobre las formulaciones actuales de tuberculosis pediátrica.
- Análisis de los avances recientes en los nuevos sistemas de administración oral de fármacos.
- Análisis FODA de las aplicaciones de la nanotecnología en la administración de medicamentos para la tuberculosis pediátrica.
Principales resultados:
- Las formulaciones pediátricas existentes para la tuberculosis a menudo no son adecuadas, lo que lleva a una dosificación inexacta y una adherencia deficiente.
- Los nuevos sistemas de administración de medicamentos son prometedores para superar los desafíos de enmascarar el sabor y la dosificación precisa.
- La nanotecnología ofrece un potencial para la entrega dirigida y mejores resultados terapéuticos en la tuberculosis pediátrica.
Conclusiones:
- Existe una necesidad crítica de formulaciones de administración de fármacos adaptadas a la pediatría para el tratamiento de la tuberculosis.
- Las innovaciones recientes en los sistemas de administración oral de fármacos están abordando las limitaciones actuales.
- La investigación futura debe centrarse en la nanotecnología para mejorar la eficacia y la adherencia del tratamiento pediátrico de la tuberculosis.
Palabras clave:
nanotecnologíaSistemas de administración oral de fármacospediatríafarmacodinámicaFarmacocinéticala tuberculosisMás Videos Relacionados
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
5.8K
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.9K
Videos de Conceptos Relacionados
01:28Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
01:26Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
01:28Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
01:29Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
01:31Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
01:29Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314